Table 1.
Control |
Bosentan |
P Values |
|||||
---|---|---|---|---|---|---|---|
Pre IH | Post IH | Pre IH | Post IH | IH | Drug | Interaction | |
Systolic blood pressure, mmHg | 139 ± 3 | 143 ± 2 | 137 ± 3 | 138 ± 3 | 0.16 | 0.35 | 0.18 |
Diastolic blood pressure, mmHg | 73 ± 1 | 76 ± 2 | 68 ± 1 | 69 ± 2 | <0.01 | <0.01 | 0.13 |
Mean blood pressure, mmHg | 94 ± 2 | 98 ± 2 | 88 ± 2 | 90 ± 2 | <0.01 | <0.01 | 0.12 |
Heart rate, beats/min | 57 ± 2 | 59 ± 3 | 58 ± 2 | 60 ± 2 | 0.19 | 0.66 | 0.39 |
Stroke volume, mL/beat | 103 ± 4 | 103 ± 4 | 107 ± 4 | 106 ± 4 | 0.92 | 0.30 | 0.76 |
Cardiac output, L/min | 5.6 ± 0.4 | 5.7 ± 0.5 | 5.8 ± 0.3 | 6.0 ± 0.3 | 0.20 | 0.27 | 0.45 |
Total peripheral resistance, mmHg·s/mL | 1.02 ± 0.05 | 1.04 ± 0.07 | 0.90 ± 0.04 | 0.90 ± 0.04 | 0.73 | 0.02 | 0.66 |
Data are reported as means ± SE from n = 12 men. Two-way repeated-measures ANOVA testing the main effect of IH (pre, post) and drug (control, bosentan) and the interaction of IH and drug (normality: Shapiro–Wilk, equal variance: Brown–Forsythe). Pairwise multiple comparison (Holm–Sidak). IH, intermittent hypoxia. Bold type signifies P < 0.05.